NAVA — Navamedic ASA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapMomentum Trap

Annual income statement for Navamedic ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	210	278	382	512	531
Cost of Revenue
Gross Profit	70.3	112	164	199	209
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	215	267	328	506	511
Operating Profit	-4.93	11.5	54	6.18	19.9
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-16.6	2.36	42.5	-6.16	-1.62
Provision for Income Taxes
Net Income After Taxes	-16.5	0.618	29.4	-13.7	-5.49
Net Income Before Extraordinary Items
Net Income	-16.5	0.618	29.4	-13.7	-5.49
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-16.5	0.618	29.4	-13.7	-5.49
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.12	0.037	1.3	0.459	0.125
Dividends per Share